SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+69.6%
5Y CAGR+31.2%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+69.6%/yr
Annual compound
5Y CAGR
+31.2%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.9x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $151.49M | +483.4% |
| 2024 | $25.97M | -54.7% |
| 2023 | $57.30M | +84.5% |
| 2022 | $31.06M | -19.4% |
| 2021 | $38.55M | -1.2% |
| 2020 | $39.01M | +1791.9% |
| 2019 | $-2.31M | - |